Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2010 4
2011 4
2012 3
2014 4
2015 4
2016 5
2017 10
2018 3
2019 3
2020 2
2021 3
2022 5
2023 4
2024 5
2025 6
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Baronio R, Feyereislova A, Barton C, Valagussa P, Baselga J. Gianni L, et al. Among authors: climent ma. Lancet. 2010 Jan 30;375(9712):377-84. doi: 10.1016/S0140-6736(09)61964-4. Lancet. 2010. PMID: 20113825 Clinical Trial.
SEOM-SOGUG clinical guideline for urothelial cancer (2025).
Puente J, Rodríguez-Vida A, Sevillano E, Estévez SV, Fernández CÁ, Chirivella I, Climent MÁ, Fernández O, de Liaño AG, Valderrama BP. Puente J, et al. Among authors: climent ma. Clin Transl Oncol. 2025 Nov;27(11):4142-4159. doi: 10.1007/s12094-025-04045-2. Epub 2025 Sep 17. Clin Transl Oncol. 2025. PMID: 40960583 Free PMC article.
Sorafenib in renal cell carcinoma.
Arranz JÁ, Climent MÁ, González-Larriba JL, León L, Maroto JP. Arranz JÁ, et al. Among authors: climent ma. Crit Rev Oncol Hematol. 2011 Nov;80(2):314-22. doi: 10.1016/j.critrevonc.2011.01.008. Epub 2011 Mar 21. Crit Rev Oncol Hematol. 2011. PMID: 21419641 Review.
Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management.
Bellmunt J, Valderrama BP, Puente J, Grande E, Bolós MV, Lainez N, Vázquez S, Maroto P, Climent MÁ, Garcia Del Muro X, Arranz JÁ, Durán I. Bellmunt J, et al. Among authors: climent ma. Crit Rev Oncol Hematol. 2022 Jun;174:103683. doi: 10.1016/j.critrevonc.2022.103683. Epub 2022 Apr 16. Crit Rev Oncol Hematol. 2022. PMID: 35439541 Free article. Review.
Association of PD-1, LAG-3 and TIM-3 expression on intratumoral CD8 T-cells with response to atezolizumab in a Real-World-Evidence biomarker study for advanced urothelial carcinoma patients.
de Andrea CE, Abengozar-Muela M, Arranz JÁ, Climent MA, Puente J, Vizcay Á, Montero de la Fuente L, Jurado JM, Bonfill T, Santander C, Villa JC, Pujol E, Rosero AC, Gomez J, Fernández EM, Álvarez Fernández C, Ramirez I, Arnáiz P, López-Janeiro Á, Melero I, Sanmamed MF, Pérez-Gracia JL. de Andrea CE, et al. Among authors: climent ma. Oncoimmunology. 2025 Dec;14(1):2538687. doi: 10.1080/2162402X.2025.2538687. Epub 2025 Aug 8. Oncoimmunology. 2025. PMID: 40778981 Free article.
Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors.
Garcia de Herreros M, Jiménez N, Rodríguez-Carunchio L, Lillo E, Marín-Aguilera M, Ferrer-Mileo L, Aversa C, García-Esteve S, Padrosa J, Trias I, Fernández-Mañas L, Font A, Chirivella I, Figols M, Climent MÁ, Prat A, Reig Ò, Mellado B. Garcia de Herreros M, et al. Among authors: climent ma. Eur Urol Open Sci. 2024 Oct 21;70:86-90. doi: 10.1016/j.euros.2024.10.008. eCollection 2024 Dec. Eur Urol Open Sci. 2024. PMID: 39502104 Free PMC article.
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Jiménez N, Garcia de Herreros M, Reig Ò, Marín-Aguilera M, Aversa C, Ferrer-Mileo L, García-Esteve S, Rodríguez-Carunchio L, Trias I, Font A, Rodriguez-Vida A, Climent MÁ, Cros S, Chirivella I, Domènech M, Figols M, Carles J, Suárez C, Herrero Rivera D, González-Billalabeitia E, Cívico C, Sala-González N, Ruiz de Porras V, Ribal MJ, Prat A, Mellado B. Jiménez N, et al. Among authors: climent ma. Eur Urol Oncol. 2024 Aug;7(4):954-964. doi: 10.1016/j.euo.2023.12.012. Epub 2024 Mar 1. Eur Urol Oncol. 2024. PMID: 38429210 Free article.
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.
Garrido Siles M, López-Beltran A, Pelechano P, García Vicente AM, Gironés Sarrió R, González-Haba Peña E, Rodríguez Antolín A, Zapatero A, Arranz JÁ, Climent MÁ; Spanish Oncology Genitourinary Multidisciplinary Working Group. Garrido Siles M, et al. Among authors: climent ma. Cancers (Basel). 2022 Aug 17;14(16):3968. doi: 10.3390/cancers14163968. Cancers (Basel). 2022. PMID: 36010964 Free PMC article. Review.
59 results